BMC Cancer

official impact factor 3.15

Open Access Highly Access

Breast cancer stem cells: tools and models to rely on

Emmanuelle Charafe-Jauffret, Christophe Ginestier and Daniel Birnbaum*

BMC Cancer 2009, 9:202 doi:10.1186/1471-2407-9-202

Accesses  

  • Last 30 days: 442 accesses
  • Last 365 days: 4055 accesses
  • All time: 11698 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells

Kaiji Hu, Jennifer H Law, Abbas Fotovati, Sandra E Dunn Breast Cancer Research 2012, 14:R22 (6 February 2012)

Research   Open Access

Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism

Sripathi M Sureban, Randal May, Fadee G Mondalek, Dongfeng Qu, Sivapriya Ponnurangam, Panayotis Pantazis, Shrikant Anant, Rama P Ramanujam, Courtney W Houchen Journal of Nanobiotechnology 2011, 9:40 (19 September 2011)